IPP Bureau
Agilent announces new ProteoAnalyzer system
By IPP Bureau - January 17, 2024
Automated parallel capillary electrophoresis system simplifies protein analysis
Pharmatech Associates adds Dr. Praveen Tyle to Board of Trustees
By IPP Bureau - January 17, 2024
Parexel collaborates with Japanese Foundation for cancer research
By IPP Bureau - January 17, 2024
Collaboration streamlines patient access to oncology clinical trials
Tritan used for safer medical infusion therapy
By IPP Bureau - January 17, 2024
This turn valve is considered revolutionary because it supports back-to-back drug infusion through the same device
Bayer, Sun Pharma sign marketing and distribution agreement for second brand of Finerenone in India
By IPP Bureau - January 17, 2024
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
CuraTeQ Biologics receives recommendation for grant of marketing authorization of 'biosimilar trastuzumab'
By IPP Bureau - January 17, 2024
Trastuzumab biosimilar is a humanized monoclonal antibody for treating metastatic breast cancer
INVpack presents microdosing precision in pharma and nutritional packaging for India
By IPP Bureau - January 16, 2024
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
Nethradhama’s conference on ophthalmology sees launch of advanced eye care technologies
By IPP Bureau - January 16, 2024
The three-day event in Bengaluru was conducted in collaboration with the Karnataka Ophthalmology Society (KOS) and the Bangalore Ophthalmology Society (BOS)
Apollo Hospital Seshadripuram partners with LifeSigns
By IPP Bureau - January 16, 2024
Inducts advanced AI-Powered 24x7 remote patient monitoring system
NovaBay and Sonoma to market Avenova-branded products in EU through Sonoma’s distributor network
By IPP Bureau - January 16, 2024
Sonoma will manufacture Ocudox by Avenova with packaging similar to NovaBay’s Avenova products
Nucala approved in China for use in severe asthma with an eosinophilic phenotype
By IPP Bureau - January 16, 2024
Approval based on a separate phase III trial among Chinese patients reinforcing mepolizumab’s efficacy and safety data
30 crore Ayushman cards created under Ayushman Bharat Pradhan Mantri Jan Arogya Yojana
By IPP Bureau - January 15, 2024
Beneficiaries can create Ayushman Card from their mobile phone using Ayushman App which has been downloaded 52 lakh times since its launch on 13th September, 2023
Dr. Jitendra Singh launches AI supported Telemedicine Mobile Clinic in Udhampur
By IPP Bureau - January 15, 2024
The latest upgraded Tele Clinic is Artificial Intelligence (AI) - driven to provide healthcare facilities in far flung areas of the region, where such facilities are either not available or inadequately available
Lupin Life hosted Second Edition of Aptivate Champion Run for Kids
By IPP Bureau - January 15, 2024
The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars
